KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CRISPR Therapeutics AG (CRSP) Tax Provisions: 2014-2024

Historic Tax Provisions for CRISPR Therapeutics AG (CRSP) over the last 11 years, with Dec 2024 value amounting to $4.1 million.

  • CRISPR Therapeutics AG's Tax Provisions fell 31.22% to $619,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year increase of 18.75%. This contributed to the annual value of $4.1 million for FY2024, which is 22.92% up from last year.
  • As of FY2024, CRISPR Therapeutics AG's Tax Provisions stood at $4.1 million, which was up 22.92% from $3.3 million recorded in FY2023.
  • Over the past 5 years, CRISPR Therapeutics AG's Tax Provisions peaked at $4.1 million during FY2024, and registered a low of $685,000 during FY2022.
  • In the last 3 years, CRISPR Therapeutics AG's Tax Provisions had a median value of $3.3 million in 2023 and averaged $2.7 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 63.37% in 2022, then surged by 383.50% in 2023.
  • CRISPR Therapeutics AG's Tax Provisions (Yearly) stood at $809,000 in 2020, then soared by 131.15% to $1.9 million in 2021, then slumped by 63.37% to $685,000 in 2022, then spiked by 383.50% to $3.3 million in 2023, then climbed by 22.92% to $4.1 million in 2024.